According to ImmunoPrecise Antibodies's latest financial reports the company's current earnings (TTM) are -C$29.36 M. In 2023 the company made an earning of -C$15.68 M an increase over its 2022 earnings that were of -C$26.13 M.The earnings displayed on this page is the company's Pretax Income.